SUPPLEMENT

Q1 2025 — Financial statements (US GAAP)

Q1 2025PDF · 8 pages108 KB
ASML - Summary US GAAP Consolidated Statements of Operations
Three months ended,
Mar 31, Mar 30,
(unaudited, in millions €, except per share data) 2024 2025
Net system sales 3,965.9 5,740.4
Net service and field option sales 1,324.1 2,001.1
Total net sales 5,290.0 7,741.5
Total cost of sales (2,593.4) (3,561.8)
Gross profit 2,696.6 4,179.7
Research and development costs (1,031.9) (1,161.1)
Selling, general and administrative costs (273.3) (280.7)
Income from operations 1,391.4 2,737.9
Interest and other, net 26.2 49.2
Income before income taxes 1,417.6 2,787.1
Income tax expense (224.0) (465.1)
Income after income taxes 1,193.6 2,322.0
Profit related to equity method investments 30.2 33.0
Net income 1,223.8 2,355.0
Basic net income per ordinary share 3.11 6.00
Diluted net income per ordinary share 3.11 6.00
Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic 393.4 392.3
Diluted 393.7 392.5
ASML - Ratios and Other Data
Three months ended,
Mar 31, Mar 30,
(unaudited, in millions €, except otherwise indicated) 2024 2025
Gross profit as a percentage of net sales 51.0 % 54.0 %
Income from operations as a percentage of net sales 26.3 % 35.4 %
Net income as a percentage of net sales 23.1 % 30.4 %
Income taxes as a percentage of income before income taxes 15.8 % 16.7 %
Shareholders’ equity as a percentage of total assets 35.3 % 38.5 %
Sales of lithography systems (in units) 1 70 77
Net bookings 2 3,611 3,936
Number of payroll employees in FTEs 40,940 43,129
Number of temporary employees in FTEs 1,773 998
1. Lithography systems do not include metrology and inspection systems.
2. Net bookings include all system sales orders and inflation-related adjustments, for which written authorizations have been accepted.

-- 1 of 8 --

ASML - Summary US GAAP Consolidated Balance Sheets
Dec 31, Mar 30,
(unaudited, in millions €) 2024 2025
ASSETS
Cash and cash equivalents 12,735.9 9,098.4
Short-term investments 5.4 5.2
Accounts receivable, net 4,477.5 4,597.5
Finance receivables, net 82.6 381.7
Current tax assets 283.6 143.2
Contract assets 320.6 407.3
Inventories, net 10,891.5 11,024.7
Loans receivable — 17.8
Other assets 1,940.3 1,848.6
Total current assets 30,737.4 27,524.4
Finance receivables, net 317.2 153.4
Deferred tax assets 1,940.7 1,861.0
Loans receivable 1,456.6 1,443.4
Other assets 790.8 859.2
Equity method investments 903.0 938.9
Goodwill 4,588.6 4,588.6
Other intangible assets, net 621.3 591.6
Property, plant and equipment, net 6,846.8 7,152.9
Right-of-use assets 387.2 365.4
Total non-current assets 17,852.2 17,954.4
Total assets 48,589.6 45,478.8
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities 20,051.4 18,123.9
Total current liabilities 20,051.4 18,123.9
Long-term debt 3,677.3 3,681.0
Deferred and other tax liabilities 299.2 335.9
Contract liabilities 5,625.4 5,400.6
Accrued and other liabilities 459.5 436.7
Total non-current liabilities 10,061.4 9,854.2
Total liabilities 30,112.8 27,978.1
Total shareholders’ equity 18,476.8 17,500.7
Total liabilities and shareholders’ equity 48,589.6 45,478.8

-- 2 of 8 --

ASML - Summary US GAAP Consolidated Statements of Cash Flows
Three months ended,
Mar 31, Mar 30,
(unaudited, in millions €) 2024 2025
CASH FLOWS FROM OPERATING ACTIVITIES
Net income 1,223.8 2,355.0
Adjustments to reconcile net income to net cash flows from
operating activities:
Depreciation and amortization 214.4 241.3
Impairment and loss (gain) on disposal 4.2 2.1
Share-based compensation expense 19.8 40.0
Inventory reserves 121.5 59.6
Deferred tax expense (benefit) (2.7) 79.1
Equity method investments (33.9) (34.9)
Changes in assets and liabilities (1,799.0) (2,800.8)
Net cash provided by (used in) operating activities (251.9) (58.6)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment (417.3) (415.0)
Purchase of intangible assets (6.5) (1.5)
Purchase of short-term investments (300.0) —
Loans issued and other investments 0.2 0.8
Net cash provided by (used in) investing activities (723.6) (415.7)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid (571.0) (597.2)
Purchase of treasury shares (385.1) (2,592.6)
Net proceeds from issuance of shares 29.3 38.0
Repayment of debt and finance lease obligations (0.6) 0.4
Net cash provided by (used in) financing activities (927.4) (3,151.4)
Net cash flows (1,902.9) (3,625.7)
Effect of changes in exchange rates on cash (1.0) (11.8)
Net increase (decrease) in cash and cash equivalents (1,903.9) (3,637.5)
Cash and cash equivalents at beginning of the period 7,004.7 12,735.9
Cash and cash equivalents at end of the period 5,100.8 9,098.4

-- 3 of 8 --

ASML - Quarterly Summary US GAAP Consolidated Statements of
Operations
Three months ended,
Mar 31, Jun 30, Sep 29, Dec 31, Mar 30,
(unaudited, in millions €, except per share data) 2024 2024 2024 2024 2025
Net system sales 3,965.9 4,760.9 5,926.0 7,115.9 5,740.4
Net service and field option sales 1,324.1 1,481.9 1,541.3 2,146.9 2,001.1
Total net sales 5,290.0 6,242.8 7,467.3 9,262.8 7,741.5
Total cost of sales (2,593.4) (3,030.6) (3,673.9) (4,473.0) (3,561.8)
Gross profit 2,696.6 3,212.2 3,793.4 4,789.8 4,179.7
Research and development costs (1,031.9) (1,100.6) (1,055.2) (1,116.0) (1,161.1)
Selling, general and administrative costs (273.3) (277.0) (297.0) (318.4) (280.7)
Income from operations 1,391.4 1,834.6 2,441.2 3,355.4 2,737.9
Interest and other, net 26.2 (11.9) (0.8) 6.3 49.2
Income before income taxes 1,417.6 1,822.7 2,440.4 3,361.7 2,787.1
Benefit from (provision for) income taxes (224.0) (291.6) (441.2) (723.8) (465.1)
Income after income taxes 1,193.6 1,531.1 1,999.2 2,637.9 2,322.0
Profit related to equity method investments 30.2 46.8 77.3 55.5 33.0
Net income 1,223.8 1,577.9 2,076.5 2,693.4 2,355.0
Basic net income per ordinary share 3.11 4.01 5.28 6.85 6.00
Diluted net income per ordinary share 3.11 4.01 5.28 6.84 6.00
Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic 393.4 393.2 393.2 393.3 392.3
Diluted 393.7 393.5 393.6 393.6 392.5
ASML - Quarterly Summary Ratios and Other Data
Three months ended,
Mar 31, Jun 30, Sep 29, Dec 31, Mar 30,
(unaudited, in millions €, except otherwise indicated) 2024 2024 2024 2024 2025
Gross profit as a percentage of net sales 51.0 % 51.5 % 50.8 % 51.7 % 54.0 %
Income from operations as a percentage of net sales 26.3 % 29.4 % 32.7 % 36.2 % 35.4 %
Net income as a percentage of net sales 23.1 % 25.3 % 27.8 % 29.1 % 30.4 %
Income taxes as a percentage of income before income taxes 15.8 % 16.0 % 18.1 % 21.5 % 16.7 %
Shareholders’ equity as a percentage of total assets 35.3 % 36.1 % 38.7 % 38.0 % 38.5 %
Sales of lithography systems (in units) 1 70 100 116 132 77
Net bookings 2 3,611 5,567 2,633 7,088 3,936
Number of payroll employees in FTEs 40,940 41,505 42,372 42,786 43,129
Number of temporary employees in FTEs 1,773 1,584 1,417 1,241 998
1. Lithography systems do not include metrology and inspection systems.
2. Net bookings include all system sales orders and inflation-related adjustments, for which written authorizations have been accepted.

-- 4 of 8 --

ASML - Quarterly Summary US GAAP Consolidated Balance Sheets
Mar 31, Jun 30, Sep 29, Dec 31, Mar 30,
(unaudited, in millions €) 2024 2024 2024 2024 2025
ASSETS
Cash and cash equivalents 5,100.8 4,813.6 4,979.3 12,735.9 9,098.4
Short-term investments 305.3 205.3 5.2 5.4 5.2
Accounts receivable, net 3,585.5 4,475.8 5,160.6 4,477.5 4,597.5
Finance receivables, net 1,441.2 977.0 640.7 82.6 381.7
Current tax assets 649.3 684.8 324.4 283.6 143.2
Contract assets 302.6 435.0 553.6 320.6 407.3
Inventories, net 9,864.5 10,972.3 11,414.5 10,891.5 11,024.7
Loans receivable — — — — 17.8
Other assets 1,890.5 1,889.4 1,785.7 1,940.3 1,848.6
Total current assets 23,139.7 24,453.2 24,864.0 30,737.4 27,524.4
Finance receivables, net 13.8 64.0 370.5 317.2 153.4
Deferred tax assets 1,875.2 1,872.4 1,939.0 1,940.7 1,861.0
Loans receivable 929.5 929.3 928.6 1,456.6 1,443.4
Other assets 648.5 702.8 733.5 790.8 859.2
Equity method investments 951.5 1,002.3 1,083.4 903.0 938.9
Goodwill 4,588.6 4,588.6 4,588.6 4,588.6 4,588.6
Other intangible assets, net 711.1 686.4 652.9 621.3 591.6
Property, plant and equipment, net 5,841.4 6,084.0 6,211.9 6,846.8 7,152.9
Right-of-use assets 343.3 358.0 393.7 387.2 365.4
Total non-current assets 15,902.9 16,287.8 16,902.1 17,852.2 17,954.4
Total assets 39,042.6 40,741.0 41,766.1 48,589.6 45,478.8
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities 15,048.7 16,132.3 16,025.8 20,051.4 18,123.9
Total current liabilities 15,048.7 16,132.3 16,025.8 20,051.4 18,123.9
Long-term debt 4,612.0 4,608.2 4,692.2 3,677.3 3,681.0
Deferred and other tax liabilities 400.4 351.9 346.9 299.2 335.9
Contract liabilities 4,744.7 4,463.0 4,103.9 5,625.4 5,400.6
Accrued and other liabilities 442.7 474.4 445.7 459.5 436.7
Total non-current liabilities 10,199.8 9,897.5 9,588.7 10,061.4 9,854.2
Total liabilities 25,248.5 26,029.8 25,614.5 30,112.8 27,978.1
Total shareholders’ equity 13,794.1 14,711.2 16,151.6 18,476.8 17,500.7
Total liabilities and shareholders’ equity 39,042.6 40,741.0 41,766.1 48,589.6 45,478.8

-- 5 of 8 --

ASML - Quarterly Summary US GAAP Consolidated Statements of Cash
Flows
Three months ended,
Mar 31, Jun 30, Sep 29, Dec 31, Mar 30,
(unaudited, in millions €) 2024 2024 2024 2024 2025
CASH FLOWS FROM OPERATING ACTIVITIES
Net income 1,223.8 1,577.9 2,076.5 2,693.4 2,355.0
Adjustments to reconcile net income to net cash flows from
operating activities:
Depreciation and amortization 214.4 227.5 235.7 241.0 241.3
Impairment and loss (gain) on disposal 4.2 13.7 6.8 11.1 2.1
Share-based compensation expense 19.8 46.5 53.3 53.0 40.0
Inventory reserves 121.5 110.7 154.8 167.7 59.6
Deferred tax expense (benefit) (2.7) 0.8 (114.6) (28.3) 79.1
Equity method investments (33.9) (50.6) (81.0) 169.9 (34.9)
Changes in assets and liabilities (1,799.0) (1,003.1) (1,381.6) 6,237.0 (2,800.8)
Net cash provided by (used in) operating activities (251.9) 923.4 949.9 9,544.8 (58.6)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment (417.3) (531.0) (414.9) (704.0) (415.0)
Purchase of intangible assets (6.5) (7.0) (0.9) (1.5) (1.5)
Purchase of short-term investments (300.0) (0.5) (3.8) (0.9) —
Maturity of short-term investments — 100.4 203.9 0.9 —
Loans issued and other investments 0.2 0.3 0.7 (527.4) 0.8
Net cash provided by (used in) investing activities (723.6) (437.8) (215.0) (1,232.9) (415.7)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid (571.0) (688.3) (595.8) (597.8) (597.2)
Purchase of treasury shares (385.1) (114.9) — — (2,592.6)
Net proceeds from issuance of shares 29.3 31.2 31.5 32.0 38.0
Net proceeds from issuance of notes, net of issuance costs — — — 22.5 —
Repayment of debt and finance lease obligations (0.6) (0.3) (0.7) (24.1) 0.4
Net cash provided by (used in) financing activities (927.4) (772.3) (565.0) (567.4) (3,151.4)
Net cash flows (1,902.9) (286.7) 169.9 7,744.5 (3,625.7)
Effect of changes in exchange rates on cash (1.0) (0.5) (4.2) 12.1 (11.8)
Net increase (decrease) in cash and cash equivalents (1,903.9) (287.2) 165.7 7,756.6 (3,637.5)
Cash and cash equivalents at beginning of the period 7,004.7 5,100.8 4,813.6 4,979.3 12,735.9
Cash and cash equivalents at end of the period 5,100.8 4,813.6 4,979.3 12,735.9 9,098.4

-- 6 of 8 --

Notes to the Summary US GAAP Consolidated Financial Statements
Basis of preparation
The accompanying unaudited Summary Consolidated Financial Statements have been prepared in conformity with the
accounting principles generally accepted in the United States of America ("US GAAP").
For further details on our annual disclosure requirements under US GAAP, including our significant accounting policies, these
interim unaudited Summary Consolidated Financial Statements should be read in conjunction with the Consolidated Financial
Statements and Notes included within our 2024 Annual Report based on US GAAP, which is available on www.asml.com.

-- 7 of 8 --

Forward Looking Statements
This document and related discussions contain statements that are forward-looking within the meaning of the U.S. Private
Securities Litigation Reform Act of 1995, including statements with respect to plans, strategies, expected trends, including
trends in the semiconductor industry and end markets and business environment trends, expected growth in the semiconductor
industry by 2030, our expectation that AI will be the key driver for the industry and the expected impact of AI demand on our
business and results, our expectation that lithography will remain at the heart of customer innovation, expected demand,
bookings, outlook of market segments, outlook and expected financial results including expected results for Q2 2025, including
net sales, Installed Base Management sales, gross margin, R&D costs, SG&A costs, outlook for full year 2025, including
expected full year 2025 total net sales, gross margin, estimated annualized effective tax rate and expected growth in IBM sales,
the expectation that 2025 and 2026 will be growth years, statements made at our 2024 Investor Day, including revenue and
gross margin opportunity for 2030, statements with respect to the recent US tariff announcements and the expected impact of
such tariffs on our business and results, our expectation to continue to return significant amounts of cash to shareholders
through growing dividends and share buybacks, statements with respect to our share buyback program, and statements with
respect to dividends, statements with respect to expected performance and capabilities of our systems and customer plans,
statements with respect to our ESG strategy and other non- historical statements. You can generally identify these statements by
the use of words like “may”, “expect”, “will”, “could”, “should”, “project”, “believe”, “anticipate”, “expect”, “plan”, “estimate”,
“forecast”, “potential”, “intend”, “continue”, “target”, “future”, “progress”, “goal”, “model”, “opportunity” and variations of these
words or comparable words. These statements are not historical facts, but rather are based on current expectations, estimates,
assumptions, plans and projections about our business and our future financial results and readers should not place undue
reliance on them. Forward- looking statements do not guarantee future performance and involve a number of substantial known
and unknown risks and uncertainties. These risks and uncertainties include, without limitation, risks relating to customer
demand, semiconductor equipment industry capacity, worldwide demand for semiconductors and semiconductor manufacturing
capacity, lithography tool utilization and semiconductor inventory levels, general trends and consumer confidence in the
semiconductor industry, the impact of general economic conditions, including the impact of the current macroeconomic
environment on the semiconductor industry, uncertainty around a market recovery including the timing thereof, the ultimate
impact of AI on our industry and business, the impact of inflation, interest rates, wars and geopolitical developments, the impact
of pandemics, the performance of our systems, the success of technology advances and the pace of new product development
and customer acceptance of and demand for new products, our production capacity and ability to adjust capacity to meet
demand, supply chain capacity, timely availability of parts and components, raw materials, critical manufacturing equipment and
qualified employees, our ability to produce systems to meet demand, the number and timing of systems ordered, shipped and
recognized in revenue, risks relating to fluctuations in net bookings and our ability to convert bookings into sales, the risk of
order cancellation or push outs and restrictions on shipments of ordered systems under export controls, risks relating to the
trade environment, import/export and national security regulations and orders and their impact on us, including the impact of
changes in export regulations and the impact of such regulations on our ability to obtain necessary licenses and to sell our
systems and provide services to certain customers, the impact of the recent tariff announcements, exchange rate fluctuations,
changes in tax rates, available liquidity and free cash flow and liquidity requirements, our ability to refinance our indebtedness,
available cash and distributable reserves for, and other factors impacting, dividend payments and share repurchases, the
number of shares that we repurchase under our share repurchase program, our ability to enforce patents and protect intellectual
property rights and the outcome of intellectual property disputes and litigation, our ability to meet ESG goals and execute our
ESG strategy, other factors that may impact ASML’s business or financial results, and other risks indicated in the risk factors
included in ASML’s Annual Report on Form 20-F for the year ended December 31, 2024 and other filings with and submissions
to the US Securities and Exchange Commission. These forward-looking statements are made only as of the date of this
document. We undertake no obligation to update any forward-looking statements after the date of this report or to conform such
statements to actual results or revised expectations, except as required by law.

-- 8 of 8 --